| Name | Title | Contact Details |
|---|
Founded by identical twins, Rose Cook and Lynn Faughey, The FlexPro Group is a specialty consulting firm, focused on delivering project management expertise to companies in the Life Sciences. Since 2008, FlexPro has been recognized as a premier provider of project management consulting services to this industry. For the 3rd year in a row, FlexPro was recognized by Inc. Magazine as one of America`s fastest-growing private companies: #859 (2014), #288 (2013) and #104 (2012). Also ranked 6th on the Philadelphia 100 lists of fastest growing privately-held companies (both in 2013 and 2012). Ranked among the Top 25 Management Consulting Firms in Philadelphia Business Journal`s "The List" (2017).
Source! Nutrition is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Bio-Tissue®, a subsidiary of TissueTech™, is the leader in regenerative biologic therapies and ocular hygiene solutions for eye care professionals. Established in 1997, Bio-Tissue® serves an unmet need for better surgical and therapeutic alternatives for helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye. Eye care professionals understand that good medicine is based on good science. Bio-Tissue® prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data, and provide innovative solutions for a range of ocular surface and lid margin diseases. Bio-Tissue® adheres to the FDA tissue and medical device guidelines.
Baptist Hospital, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Baptist Hospital, Inc. is based in Nashville, TN. You can find more information on Baptist Hospital, Inc. at www.baptisthospital.com
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.